1. Home
  2. HUBC vs LGVN Comparison

HUBC vs LGVN Comparison

Compare HUBC & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.22

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

BUY

Current Price

$1.59

Market Cap

7.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
HUBC
LGVN
Founded
2017
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
7.8M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
HUBC
LGVN
Price
$0.22
$1.59
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
★ 931.2K
69.7K
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.76
EPS
★ N/A
N/A
Revenue
N/A
★ $709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$396.46
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.06
$0.48
52 Week High
$8.68
$7.60

Technical Indicators

Market Signals
Indicator
HUBC
LGVN
Relative Strength Index (RSI) 35.92 33.00
Support Level $0.11 $0.61
Resistance Level $0.31 $7.30
Average True Range (ATR) 0.12 0.22
MACD -0.07 -0.05
Stochastic Oscillator 1.63 16.28

Price Performance

Historical Comparison
HUBC
LGVN

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in developing reliable quality assurance systems that support process and product enhancement and also operates in the industry of secured data fabric. The company serves various organizations and institutions operating in the security, electronics, aviation, telecommunications, and banking. The company has two operating segments: Product and Technology Segment and Professional Services Segment. The majority of revenue comes from the professional services segment, which provides data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, integrating and ongoing servicing of cybersecurity, risk management, reliability and security projects and fully managed corporate cybersecurity services.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: